Start with one part diuretic. Add one part ACE inhibitor, and sprinkle in one part beta blocker. Then add a dose of statins, and top it off with a portion of antiplatelets. Here we have the proposed recipe for a singular pill that some experts believe will eventually help us stick a fork in heart disease. Yet there are pharmacologic concerns and certainly clinical trials to pass before this drug comes to a practice near you. That said, it's fair to wonder: how close are we? Dr. Salim Yusuf, professor of medicine and the director of the Population Health Research Institute at McMaster University in Hamilton, Ontario, Canada, is the lead author of one of the most recent polypill clinical trials, presented at the American College of Cardiology's 2009 Scientific Sessions. Dr. Yusuf joins host Dr. Janet Wright to give us an update on the global effort to create a polypill that will improve compliance, increase convenience and reduce cost.
How Close Are We to a Cardiac Polypill?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Start with one part diuretic. Add one part ACE inhibitor, and sprinkle in one part beta blocker. Then add a dose of statins, and top it off with a portion of antiplatelets. Here we have the proposed recipe for a singular pill that some experts believe will eventually help us stick a fork in heart disease. Yet there are pharmacologic concerns and certainly clinical trials to pass before this drug comes to a practice near you. That said, it's fair to wonder: how close are we? Dr. Salim Yusuf, professor of medicine and the director of the Population Health Research Institute at McMaster University in Hamilton, Ontario, Canada, is the lead author of one of the most recent polypill clinical trials, presented at the American College of Cardiology's 2009 Scientific Sessions. Dr. Yusuf joins host Dr. Janet Wright to give us an update on the global effort to create a polypill that will improve compliance, increase convenience and reduce cost.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Partnering with Patients: Building Effective Communication and Support in HF Care
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?